UNSPSC 51332524: Moperone hydrochloride

This classification denotes an anxiolytic C22H26FNO2.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2Z2633815T, chemically known as butyrophenone, 4'-fluoro-4-(4-hydroxy-4-p-tolylpiperidino)-, hydrochloride, but more generally known as moperone hydrochloride, which bears US NIH Compound Identifier 19747. European Medicines Agency schedules Moperone hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03326MIG.

Most nations, for tariff and trade purposes, schedule moperone hydrochloride under HS 29333999 and SITC 51574. As of Q4 2014, MOPERONE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. SMILES: CC1CCC(CC1)C2(CCN(CC2)CCCC(=O)C3CCC(CC3)F)O.CL.

UNSPSC 51332524 Moperone hydrochloride is a Commodity code that does not align with the state and local procurement activity currently tagged under it. The single recent opportunity in the dataset—Seminole County, Florida's IFB60459723LAS—solicits naloxone and drug deactivation systems, neither of which are moperone hydrochloride. The county is procuring 1,900 units of naloxone and 800 safe drug deactivation systems annually for community health initiatives, with quarterly deliveries to the Seminole County Community Health Building in Sanford. This represents a fundamental category mismatch: naloxone is an opioid antagonist and emergency overdose reversal medication, whereas moperone hydrochloride is an antipsychotic pharmaceutical used in psychiatric treatment. The issuing body is a county health or procurement office supporting community-health-related procurement.

No meaningful activity supporting the actual scope of moperone hydrochloride procurement appears in recent state and local solicitations. The Seminole County opportunity, which closed on July 26, 2023, was conducted through IFB with electronic submission via the county's e-Procurement Portal and required compliance with drug-free workplace certification, E-Verify, and federal regulations tied to potential FEMA funding. Without additional opportunities demonstrating genuine demand for moperone hydrochloride across state and local health systems, school districts, correctional facilities, or other public bodies, the code shows no actionable market signal for business development purposes at this time.